HomeCompareHUM vs SYK

HUM vs SYK: Dividend Comparison 2026

HUM yields 2.13% · SYK yields 1.04%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HUM wins by $46.1K in total portfolio value
10 years
HUM
HUM
● Live price
2.13%
Share price
$166.00
Annual div
$3.54
5Y div CAGR
46.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$89.4K
Annual income
$29,002.59
Full HUM calculator →
SYK
SYK
● Live price
1.04%
Share price
$326.10
Annual div
$3.40
5Y div CAGR
46.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$43.3K
Annual income
$8,282.98
Full SYK calculator →

Portfolio growth — HUM vs SYK

📍 HUM pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHUMSYK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HUM + SYK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HUM pays
SYK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HUM
Annual income on $10K today (after 15% tax)
$181.27/yr
After 10yr DRIP, annual income (after tax)
$24,652.20/yr
SYK
Annual income on $10K today (after 15% tax)
$88.62/yr
After 10yr DRIP, annual income (after tax)
$7,040.53/yr
At 15% tax rate, HUM beats the other by $17,611.67/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HUM + SYK for your $10,000?

HUM: 50%SYK: 50%
100% SYK50/50100% HUM
Portfolio after 10yr
$66.3K
Annual income
$18,642.79/yr
Blended yield
28.10%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on SYK right now

HUM
Analyst Ratings
14
Buy
27
Hold
2
Sell
Consensus: Hold
Price Target
$235.00
+41.6% upside vs current
Range: $146.00 — $345.00
Altman Z
4.0
Piotroski
6/9
SYK
Analyst Ratings
1
Strong
35
Buy
14
Hold
Consensus: Buy
Price Target
$428.67
+31.5% upside vs current
Range: $390.00 — $469.00
Altman Z
4.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HUM buys
13
SYK buys
0
PoliticianChamberTickerTypeAmountDate
Julia Letlow🏢 House$HUM▼ Sell$1,001 - $15,0002026-02-10
Gilbert Cisneros🏢 House$HUM▼ Sell$1,001 - $15,0002025-11-12
Michael McCaul🏢 House$HUM▼ Sell$15,001 - $50,0002025-11-04
Lisa McClain🏢 House$HUM▲ Buy$1,001 - $15,0002025-09-25
Julia Letlow🏢 House$HUM▲ Buy$1,001 - $15,0002025-08-08
Gilbert Cisneros🏢 House$HUM▲ Buy$1,001 - $15,0002025-08-05
Ro Khanna🏢 House$HUM▲ Buy$1,001 - $15,0002025-07-25
Lisa McClain🏢 House$HUM▲ Buy$1,001 - $15,0002025-06-24
Gilbert Cisneros🏢 House$HUM▼ Sell$1,001 - $15,0002025-05-30
Gilbert Cisneros🏢 House$HUM▼ Sell$1,001 - $15,0002025-05-30
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHUMSYK
Forward yield2.13%1.04%
Annual dividend / share$3.54$3.40
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR46.1%46.2%
Portfolio after 10y$89.4K$43.3K
Annual income after 10y$29,002.59$8,282.98
Total dividends collected$63.4K$21.0K
Payment frequencyquarterlyquarterly
SectorHealthcareHealthcare
Analyst consensusHoldBuy
Analyst price target$235.00$428.67

Year-by-year: HUM vs SYK ($10,000, DRIP)

YearHUM PortfolioHUM Income/yrSYK PortfolioSYK Income/yrGap
1← crossover$11,012$311.56$10,852$152.43+$160.00HUM
2$12,251$468.45$11,838$226.03+$413.00HUM
3$13,820$711.61$13,004$336.89+$816.00HUM
4$15,883$1,096.11$14,420$505.63+$1.5KHUM
5$18,715$1,720.11$16,195$766.09+$2.5KHUM
6$22,793$2,767.44$18,504$1,175.64+$4.3KHUM
7$28,990$4,601.98$21,635$1,835.40+$7.4KHUM
8$39,012$7,992.19$26,082$2,932.10+$12.9KHUM
9$56,428$14,685.03$32,737$4,829.68+$23.7KHUM
10$89,380$29,002.59$43,312$8,282.98+$46.1KHUM

HUM vs SYK: Complete Analysis 2026

HUMHealthcare

Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, and home solutions services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2021, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

Full HUM Calculator →

SYKHealthcare

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.

Full SYK Calculator →
📬

Get this HUM vs SYK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HUM vs SCHDHUM vs JEPIHUM vs OHUM vs KOHUM vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.